Syringe Distributor, Itama Ranoraya Distributes IDR 18 Billion Dividends To Shareholders

Illustration. (Photo: Unsplash)

JAKARTA - PT Itama Ranoraya Tbk (IRRA) plans to distribute cash dividends of IDR 18 billion to its shareholders. The amount of the dividend is equivalent to 30 percent of the net profit in 2020. Meanwhile, the rest is to strengthen the company's capital.

"The amount of dividends for the 2020 financial year distributed by IRRA is Rp. 12 per share, compared to the previous year's dividends, the amount has increased by 100 percent. With the approval of all shareholders today, the payment will be made on May 25, 2021 with the respective Cum and Ex Dividend schedules April 30 and May 3, 2021, "said Pratoto Raharjo IRRA Finance Director, after the General Meeting of Shareholders of the Finance Director of IRRA, after the Annual & Extraordinary General Meeting of Shareholders (AGMS & EGMS) in Jakarta on Thursday 22 April.

For information, in 2020, IRRA managed to record an increase in 2020 net profit of 82.3 percent (year on year / yoy) to IDR 60.52 billion compared to 2019 net profit of only IDR 33.21 billion. This increase originated from the company's revenue increase in 2020 which was recorded at IDR563.89 billion or grew 100.1 percent from 2019's revenue of IDR281.75 billion.

Prepare an investment fund of IDR 300 billion

Itama Ranoraya targets an 80-100 percent growth in revenue and net profit this year. President Director of IRRA, Heru Firdausi Syarif, said that to achieve this target, the company still relies on ADS Syringes, Apheresis Machines (Blood Plasma), Antigen Test and a new product, Avimac, an immunomodulator product that will begin to be marketed in the second quarter of this year.

In addition, this year, IRRA has budgeted capital expenditure (capex) of around Rp. 250 billion - Rp. 300 billion. As for the source of funding, several funding alternatives will be reviewed, such as bank loans and the possibility of carrying out corporate actions in the capital market.

"We will take and select the most profitable alternative funding, it could be to the capital market, it could also be with loans or existing funding sources," added Director of IRRA Pratoto Satno Raharjo, on the same occasion.

He emphasized that the funds will be used to support the company's business this year.

"For organic and inorganic needs," he said.

For your information, until the first quarter of 2021, Itama Ranoraya managed to record a company's total revenue of IDR 228.17 billion or an increase of 754.1 percent compared to revenue in the same period last year of IDR 26.71 billion.

Meanwhile, IRRA's net profit was Rp. 20.91 billion or grew by 853.6 percent compared to the net profit in the first quarter of 2020 which was only Rp. 2.2 billion.